In Vivo 5FU-Exposed Human Medullary Thyroid Carcinoma Cells Contain a Chemoresistant CD133+ Tumor–Initiating Cell Subset-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In Vivo 5FU-Exposed Human Medullary Thyroid Carcinoma Cells Contain a Chemoresistant CD133+ Tumor–Initiating Cell Subset

Published:2014-03 Issue:3 Volume:24 Page:520-532
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Kucerova Lucia¹,Feketeova Lucia²,Kozovska Zuzana¹,Poturnajova Martina¹,Matuskova Miroslava¹,Nencka Radim³,Babal Pavel²

Affiliation:

1. Laboratory of Molecular Oncology, Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovakia.

2. Department of Pathology, Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovakia.

3. Institute of Organic Chemistry and Biochemistry AS CR, Prague, Czech Republic.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2013.0277

Reference53 articles.

1. Medullary Thyroid Carcinoma

2. New therapeutic approaches to treat medullary thyroid carcinoma

3. Novel treatment of medullary thyroid cancer

4. Molecular and Other Novel Advances in Treatment of Metastatic Epithelial and Medullary Thyroid Cancers

5. Update on thyroid cancer treatment

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mouse models for cancer research – current state and the perspective;Neoplasma;2024

2. Improving susceptibility of neuroendocrine tumors to radionuclide therapies: personalized approaches towards complementary treatments;Theranostics;2024

3. RET Regulates Human Medullary Thyroid Cancer Cell Proliferation through CDK5 and STAT3 Activation;Biomolecules;2021-06-09

4. CD133 Expression in Medullary Thyroid Cancer Cells Identifies Patients with Poor Prognosis;The Journal of Clinical Endocrinology & Metabolism;2020-08-13

5. CD16 expression on neutrophils predicts treatment efficacy of capecitabine in colorectal cancer patients;BMC Immunology;2020-08-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3